Showing results (411-420 of 479) with videos related to
Sort By:
Pageof 48
International Journal of Radiation Oncology, Biology, Physics|October 1, 2013
A phase 1 study of everolimus + weekly cisplatin + intensity modulated radiation therapy in head-and-neck cancerMatthew G Fury, Nancy Y Lee, Eric Sherman, et al.Journal of Pediatric Urology|March 19, 2026
Laparoscopic Mitrofanoff procedure in children: Feasibility and outcome analysis over 18 years in a single centreSylvia Weis, Ugo Maria Pierucci, Thibault Planchamp, et al.Cancer Chemotherapy and Pharmacology|August 10, 2006
A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumorsMatthew G Fury, David B Solit, Yungpo Bernard Su, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2016
A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinomaA L Ho, L Dunn, E J Sherman, et al.Leukemia & Lymphoma|December 6, 2024
A Shared Care Model between community and transplant centers facilitates access to allogeneic and autologous transplantationJoshua A Fein, Agnes McAuliffe, Kimberly Fischer, et al.Head & Neck|March 19, 2015
Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinomaMatthew G Fury, Han Xiao, Eric J Sherman, et al.Medecine Et Maladies Infectieuses|May 1, 2018
Microbiology of French military casualties repatriated from overseas for an open traumatic injuryS Larréché, A Bousquet, C Soler, et al.International Journal of Radiation Oncology, Biology, Physics|August 12, 2016
Strategy of Using Intratreatment Hypoxia Imaging to Selectively and Safely Guide Radiation Dose De-escalation Concurrent With Chemotherapy for Locoregionally Advanced Human Papillomavirus-Related Oropharyngeal CarcinomaNancy Lee, Heiko Schoder, Brad Beattie, et al.International Journal of Radiation Oncology, Biology, Physics|May 24, 2011
Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastasesAmita Shukla-Dave, Nancy Y Lee, Jacobus F A Jansen, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2014
Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC)M G Fury, E J Sherman, S S Rao, et al.Pageof 48